ArticleClinical endoscopy2015
Endoscopic management of tumor bleeding from inoperable gastric cancer.
Article in Clinical endoscopy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cross-phenotype association analysis of gastric cancer: in-silico functional annotation based on the disease-gene network.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2023Pooled it
- Systematic treatment in gastric cancer patients with overt bleeding: A propensity score matching analysis.World journal of clinical oncology · 2024Trial
- Hemorrhagic Complications in Gastric Cancer: Current Evidence and Multidisciplinary Management Strategies.Cancers · 2026Review
- Endoscopic Treatment of Upper Gastrointestinal Bleeding.The Korean journal of helicobacter and upper gastrointestinal research · 2026Review
- An Unusual Cause of Hematemesis in a Patient Previously Treated for Cholangiocarcinoma.The Korean journal of helicobacter and upper gastrointestinal research · 2025Article
- Upper Gastrointestinal Bleeding Secondary to Gastric Invasion by Diffuse Large B-cell Lymphoma.Cureus · 2025Article
- The effectiveness of radiotherapy and transarterial embolization for advanced gastric cancer bleeding.BMC gastroenterology · 2025Article
- Optimizing care for gastric cancer with overt bleeding: Is systemic therapy a valid option?World journal of clinical oncology · 2025Article
- Hemostatic palliative radiotherapy for gastric cancer: A literature review.Technical innovations & patient support in radiation oncology · 2024Review
- Upper gastrointestinal bleeding as a warning sign of gastrointestinal cancer.Preventive medicine reports · 2024Article
- Meaning of Better Scoring System for the Patients with Cancer Bleeding in the Upper Gastrointestinal Tract.Gut and liver · 2024Article
- The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.Cancer communications (London, England) · 2024Article
- Efficacy and safety of gastroscopic hemostasis in the treatment of acute gastric hemorrhage: A meta-analysis.World journal of gastrointestinal oncology · 2023Article
- Knowledge and Awareness About Gastric Cancer Among the General Population in Al-Baha City, Saudi Arabia.Cureus · 2023Article
- Use of Endoscopic Suturing for the Treatment of Malignant Gastric Ulcer-Related Hemorrhage.ACG case reports journal · 2023Article
- Hemostatic Powders in Non-Variceal Upper Gastrointestinal Bleeding: The Open Questions.Medicina (Kaunas, Lithuania) · 2023Review
- Article
- Gastrointestinal hemorrhage in the setting of gastrointestinal cancer: Anatomical prevalence, predictors, and interventions.World journal of gastrointestinal endoscopy · 2021Article
- The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.Cancer communications (London, England) · 2021Article
- Efficacy of a novel hemostatic adhesive powder in patients with upper gastrointestinal tumor bleeding.BMC gastroenterology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumor bleeding is not a rare complication in patients with inoperable gastric cancer. Endoscopy has important roles in the diagnosis and primary treatment of tumor bleeding, similar to its roles in other non-variceal upper gastrointestinal bleeding cases. Although limited studies have been performed, endoscopic therapy has been highly successful in achieving initial hemostasis. One or a combination of endoscopic therapy modalities, such as injection therapy, mechanical therapy, or ablative therapy, can be used for hemostasis in patients with endoscopic stigmata of recent hemorrhage. However, rebleeding after successful hemostasis with endoscopic therapy frequently occurs. Endoscopic therapy may be a treatment option for successfully controlling this rebleeding. Transarterial embolization or palliative surgery should be considered when endoscopic therapy fails. For primary and secondary prevention of tumor bleeding, proton pump inhibitors can be prescribed, although their effectiveness to prevent bleeding remains to be investigated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.